|
|
|
|
A Partial Index to Articles that have Appeared in ESUN by Bruce D. Shriver, PhD Editor-in-Chief, ESUN ESUN is now in its fourth year. We have received many requests to produce an annual index for it. Given the current development tools that we are using to produce ESUN and to build and maintain our website, this is a difficult manual task. We will be making a move in the autumn to new development environment in which this will be an automated task and one in which, as a side-effect, each article will be downloadable in Adobe's PDF format. Until this is done (which will be a multi-month project after it is initiated), we are providing the following “partial index” of feature articles listed in alphabetical order by title in three categories: 1. DETAILED ARTICLES ABOUT SPECIFIC SARCOMAS 2. ARTICLES OF GENERAL INTEREST 3. OPINION PIECES Because there are literally hundreds of items and abstracts in the “Clinical Trail News”, “Odds & Ends”, “Research Corner” and "Stories of Courage and Hope" columns, we do not include them in the partial index below. We hope to provide a general search facility after our move to the new technology base is complete.
DETAILED ARTICLES ABOUT SPECIFIC SARCOMAS by James M. Lewis, MD and Vernon K. Sondak, MD
Characterization of WWOX tumor suppressor gene in osteosarcoma by Jilong Yang, MD, PhD and Wei Zhang, PhD
by R. Lor Randall, MD and Kenneth J. Hunt, MD
Clear Cell Sarcoma and Alveolar Soft Part Sarcoma by John M. Goldberg, MD and Karen Albritton, MD
Cytarabine for the Treatment of Ewing's Sarcoma by Steven G. DuBois, MD, Holcombe E. Grier, MD, and Kimberly Stegmaier, MD
Ewing’s Sarcoma Family of Tumors (ESFT) by R. Lor Randall, MD
Identification and Characterization of the Ewing’s Sarcoma Stem Cell by David Loeb, M.D., Ph.D.
Leiomyosarcoma of Bone and Soft Tissue: A Review by Michael J. Weaver, MD and John A. Abraham, MD
Leiomyosarcoma of the Uterus: A Review by Sue Ghosh, MD, Jonathan L. Hecht, MD, PhD, Tanaz R. Ferzandi, MD, M.A., and Christopher S. Awtrey, MD
by Mark C. Gebhardt, MD and Peter J. Buecker, MD
Malignant Fibrous Histiocytoma (MFH) by Carol D. Morris, MD
Malignant Peripheral Nerve Sheath Tumors (MPNST) by David S. Geller, MD and Mark C. Gebhardt, MD
by John M. Goldberg, MD and Holcombe Grier, MD
Novel Approaches for the Molecular Targeting of Ewing's Sarcoma Family of Tumors by Silke Schlottmann, PhD and Jeffrey A. Toretsky, MD
Novel Targets to Treat Osteosarcoma Lung Metastases by Nadezhda Koshkina, Ph.D. and Seth Corey, M.D.
by Peter J. Buecker, MD and Mark C. Gebhardt, MD
Osteosarcoma: A Practitioner's Quick Reference Guide by Lindy Eddinger
by Julia D. Royster, PhD
by Leonard H. Wexler, MD
Small Molecules That Can Inhibit EWS-FLI1 May Represent Novel and Specific Therapy for ESFT Patients by Jeffrey Toretsky, M.D.
by Andrea Ferrari, MD and Paola Collini, MD
by Kerrington Smith, MD, Guy Lahat, MD, Raphael Pollock, MD, PhD and Dina Lev, MD
ARTICLES OF GENERAL INTEREST A Different View of Sarcoma Research by Joan Darling, PhD
Eva Hernando, PhD
Adolescent and Young Adult Cancer Care by Karen Albritton, MD
An Overview of Some Recent Cancer-Related Nanotechnology Research by Bruce Shriver, PhD
AP23573: A Review of Recent Results by Sant P. Chawla, MD, Kamalesh Sankhala, MD, Monica Mita, MD and Anthony W. Tolcher, MD
by Jerome Groopman, MD
by Lindsay Nohr Beck, Kutluk Oktay, MD and Peter N. Schlegel, MD
Chemotherapy for Non-Rhabdomyosarcoma Soft Tissue Sarcomas of Childhood: To Treat or Not to Treat? by Crystal Mackall, MD
Chromosomal Translocations in Sarcomas: New Perspectives by Gabriela E. Mercado, MD and Frederic G. Barr, MD
Clinical Trials in Bone Sarcomas by Richard Gorlick, MD
Correlation of Lack of Participation on Clinical Trials and Lack of Progress in Bone Sarcoma by Archie Bleyer, MD
by Bruce and Beverly Shriver
ET-743: A Review of Recent Results by Margaret von Mehren, MD
For Metastases—All Sarcomas are Not Created Equal by Crystal Mackall, MD
From Easter Island Soil to Treating Sarcoma—Rapamycin Derivatives by Danny McGurl
Gene Profiling Studies on Sarcomas by Matt van de Rijn, MD
Gene Profiling: Unlocking the Inner Workings of Sarcoma Cells by Crystal Mackall MD and Javed Khan MD
On the Horizon: Gene and Virus Therapies for Sarcomas by Timothy P. Cripe, MD, PhD
Options and Follow-up Care for Women with Uterine Sarcomas by Suzie Siegel
Participatory Medicine and E-Patients by Gilles Frydman and Bruce Shriver
Salvage of the Unplanned Sarcoma Excision by Peter J. Buecker, MD
Sarcomas and Cancer Predisposition Syndromes by Abha Gupta, MD and David Malkin, MD
Targeted Therapies for Sarcomas: the next generation of treatments by David Loeb,, MD, PhD
The COG Survivor Guidelines: A View from the Pediatric Sarcoma Perspective by Joan Darling, PhD
The Wall of Fame - A Sarcoma Survivor Project by Tamara Barnes, RN, MSN, CNS, AOCN
OPINION PIECES A Rose is a Rose or a Thorn is a Thorn by Laurence Baker, DO
Are there - or should there be - pediatric sarcoma centers? by Joan Darling, PhD
CTOS Op Ed Pieces Aggressive Fibromatosis: A Problem for the Sarcoma Team by Randall Burt, MD and David Viskochil, MD, PhD
by Prof. Ian Judson, MD, FRCP
NF1 patients: risks for sarcoma and the expedited referral of concerning cases by David Viskochil. MD, PhD
by Brian Rubin, M.D.
by Robert Maki, MD, PhD
The creation of a robust registry of sarcoma patients and biological resources by Paul A. Myers, MD
by R. Lor Randall, MD
The Margin Matters: Someone's Life depends on it by R. Lor Randall, MD
There is no reason to include age as an entry criterion for any clinical trial by Paul A. Myers, MD
From a Nurse's Perspective Cancer Treatment Related Changes in Cognitive Function (a.k.a. "Chemo Brain") by Denise Reinke, APRN, BC, AOCN
by Denise Reinke, RN, NP, Kelly Scheu, MS, NP, and Marcia E. Baker, DO, FACOI
by Denise Reinke, APRN, BC, AOCN, Jessica Frailey RN, MS and Tammara Barnes, RN, MSN, CNS, AOCN
by Denise Reinke, APRN, BC, AOCN and Debra Mattison, LMSW, and Kathy Szakatis, APN
by Denise Reinke, APRN, BC, AOCN and Martha Grist, RN
Guidelines for Patients and Caregivers by Murray F. Brennan, MD
by Murray F. Brennan, MD
by Murray F. Brennan, MD
Lobbying for the "Exceptionally Rare Diseases and Conditions Act" - a unique pathway for new drugs for sarcoma patients by Mark Thornton, MD
Participatory Medicine and E-Patients Participatory Medicine and E-Patients by Gilles Frydman and Bruce Shriver, PhD
Participatory Medicine: an End to Rational Ignorance in Medicine by Gilles Frydman
Sarcoma: A Diagnosis of Patience by Peter J. Buecker, MD
Soft Tissue Sarcoma – One physician’s Viewpoint by Murray F. Brennan, MD
Some Advice for the Newly Diagnosed: with a US Armed Forces emphasis by Doug Belvin
The Genetic Information Nondiscrimination Act by Orkideh Malkoc, MS
by Bruce Shriver, PhD
The Shocking State of NCI Funding by Joan Darling, PhD
by Deborah Buks
|
